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Background:  Atrial  ﬁbrillation  (AF)  is highly  prevalent  in  patients  with  ischemic  stroke,  but  the  diagnosis
is  often  difﬁcult.
Methods: This  study  consisted  of  68  stroke  patients  in  sinus  rhythm  without  history  of AF. All  patients
underwent  P-wave  signal-averaged  electrocardiography  (P-SAECG),  echocardiography,  24-h  Holter  mon-
itoring,  and  measurement  of  plasma  B-type  natriuretic  peptide  (BNP)  concentrations  at admission.
Results:  An  abnormal  P-SAECG  was  found  in  34 of  68 stroke  patients.  In the  follow-up  period  of  11  ±  4
months,  AF  developed  in  17 patients  (AF  group).  The  remaining  51 patients  were  classiﬁed  as  the  non-AF
group.  The  prevalence  of atrial  late  potentials  (ALP)  on  P-SAECG,  and  the  number  of premature  atrial
contractions  (PACs)  were  signiﬁcantly  higher  in  the  AF  group  than  those  in the non-AF  group  (88.2%
vs  37.3%;  p <  0.001,  149  ± 120 vs  79 ± 69;  p =  0.030,  respectively).  However,  there  were  no signiﬁcant
differences  in age,  left  atrial  dimension,  or BNP  concentrations  between  both  groups.  Cox  proportional
hazards  analysis  revealed  that the presence  of ALP (risk ratio 11.15;  p = 0.002)  and  frequent  PACs (more
than 100/24  h)  (risk  ratio  4.53;  p = 0.007)  had  signiﬁcant  correlation  to  the occurrence  of  AF.
Conclusions:  ALP  may  be a novel  predictor  of AF  in  stroke  patients.  P-SAECG  should  be  considered  in stroke
of  undetermined  etiology.
2  Jap© 201
. Introduction
Atrial ﬁbrillation (AF) is highly prevalent in patients with
schemic stroke. However, the diagnosis is often difﬁcult because
f its intermittent and frequently asymptomatic nature. In patients
ith a deﬁnite diagnosis of AF, oral anticoagulant therapy is rec-
mmended for prevention of recurrent stroke. On the basis of this
ecommendation, several approaches have been proposed for ear-
ier detection of AF in stroke patients [1–3].
Signal averaged electrocardiography (SAECG) is a high-
esolution electrocardiographic technique to detect conduction
bnormalities in patients with structural heart disease. Impaired
trial conduction is one of the causes of AF, which was reported
o be detectable by P-wave SAECG (P-SAECG) [4].  Previous studies
sing P-SAECG have shown that patients with abnormal P-SAECG
ave a high risk of AF [5,6]. The aim of this study was to investigate
∗ Corresponding author at: Division of Cardiology, Hepatology, Geriatrics, and
ntegrated Medicine, Department of Internal Medicine, Nippon Medical School,
okyo 113-8603, Japan. Tel.: +81 3 3822 2131; fax: +81 3 5685 0987.
E-mail address: yodo@nms.ac.jp (K. Yodogawa).
914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.08.013anese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.
whether P-SAECG could predict the development of AF in patients
with ischemic stroke.
2. Methods
2.1. Study population
This study is prospective and consisted of 68 consecutive
patients with acute ischemic stroke presenting with sinus rhythm
without a history of AF (31 females and 37 males, 69.9 ± 9.6 years).
A history of AF was determined by the previous ECG and medi-
cal history. All patients were referred to Nippon Medical School
Chiba Hokusoh Hospital between February 2006 and June 2011,
and underwent 24-h Holter monitoring, P-SAECG, transthoracic
echocardiography, and measurement of plasma B-type natriuretic
peptide (BNP) concentrations within 5 days of admission. Patients
were excluded if AF was documented in this term. Patients with
known cardiac diseases or serious neurological sequelae were also
excluded from the present investigation. The left atrial diameter
(LAD) was measured at end systole in the parasternal long-axis
view, and plasma BNP concentrations were determined with a spe-
ciﬁc immunoradiometric assay for human BNP with commercial
vier Ltd. All rights reserved.
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Table 1
Comparison of each parameter in patients with and without AF development.
AF group (n = 17) Non-AF group (n = 51) p-Value
Age (years) 73.5 ± 10.2 69.2 ± 9.5 0.064
Male 8 29 0.422
DM 4  6 0.254
HT  14 31 0.380
Smoker 5 9 0.315
FPD  (ms) 138.5 ± 8.6 134.1 ± 8.3 0.047
RMS20 (V) 1.73 ± 0.59 2.80 ± 1.12 <0.001
ALP  15 19 <0.001
PAC  (betas/day) 149± 120 79± 69 0.030
LAD  (mm) 40.9 ± 7.1 38.1 ± 5.7 0.063
BNP (pg/ml) 94.9 ± 55.3 73.6 ± 42.4 0.071
Data are given as the mean ± standard deviation or number of patients. AF, atrial
ﬁbrillation; ALP, atrial late potentials; BNP, brain natriuretic peptide.
DM,  diabetes mellitis; FPD, ﬁltered P wave duration; HT, hypertension; LAD, left
atrial dimension; PAC, premature atrial contractions.
RMS20, root mean square voltage of the terminal 20 ms.
Table 2
Multivariate Cox proportional hazard analysis for the identiﬁcation of patients at
risk for AF.
p-Value Hazard ratio (95% CI)
Age ≥ 70 (years) 0.188 2.06 (0.7–6.1)
ALP 0.002 11.15 (2.5–49.7)
PAC > 100 (beats/day) 0.007 4.53 (1.5–13.6)
LAD ≥ 41 (mm) 0.111 2.29 (0.8–6.3)
BNP ≥ 80 (pg/ml) 0.557 1.36 (0.5–3.8)
Identiﬁcation of stroke patients who  are prone to AF will allow
for indication of anticoagulation therapy. Despite advances in
diagnostic technique, early detection of paroxysmal AF in stroke0 K. Yodogawa et al. / Journa
its (Shionoria kit; Shionogi and Kyowa Medex, Tokyo, Japan). From
4-h Holter monitoring, the number of premature atrial contrac-
ions (PACs) was  calculated. The research protocol was  approved
y the local ethics committee and informed consent was  obtained.
.2. P-wave signal averaged electrocardiography
P-SAECG recordings were obtained from the Frank XYZ leads
uring sinus rhythm using a FDX-6521 (Fukuda Denshi Co. Ltd.,
okyo, Japan) in all the subjects. A total of 200 cycles were averaged
ith the P-wave triggering system to obtain a noise level of <0.4 V.
he signals were ampliﬁed and ﬁltered with a band-pass ﬁlter at
requencies between 40 and 300 Hz. The ﬁltered P wave duration
FPD) and the root-mean-square voltage for the last 20 ms  (RMS20)
f the signal-averaged P wave were measured. The algorithm of
he P wave-triggering system of FDX-6521 was the same as that of
CM-3000 (Fukuda Denshi Co. Ltd.) [6].  Atrial late potentials (ALP)
as deﬁned as FPD > 132 ms  and RMS20 < 2.3 mV  [7].
.3. Follow-up
All patients were followed up every 4 weeks after discharge, and
xamined with 12-lead ECG. 24-h Holter monitoring was repeated
very three months after study entry. The primary endpoint was the
evelopment of AF, deﬁned as irregular and uncoordinated atrial
lectrical activity on surface ECG lasting more than 30 s.
.4. Statistical analysis
Data are expressed as mean ± standard deviation, and statisti-
al analysis was performed by Mann–Whitney tests for unpaired
ariables. Categorical data were compared using chi-square analy-
is. AF-free rates in patients with and without ALP were calculated
sing the Kaplan–Meier method, and the difference between them
as compared using the log-rank test. The determination of pro-
nostic signiﬁcance of ALP, Holter monitoring, echocardiogram,
nd plasma BNP level was explored by the multivariate Cox pro-
ortional hazards regression model analysis. A p-value < 0.05 was
onsidered signiﬁcant.
. Results
In the follow-up period of 11 ± 4 months, paroxysmal AF devel-
ped in 17 patients (AF group). The remaining 51 patients were
lassiﬁed as the non-AF group. Notably, 7 (41.2%) AF patients were
symptomatic.
The AF group showed higher prevalence of ALP compared to that
f the non-AF group (88.2% vs 37.3%, p < 0.001; Table 1). Represen-
ative cases of P-SAECG in both groups are shown in Fig. 1. Mean
PD and RMS20 in the AF group signiﬁcantly differed from those
n the non-AF group (FPD: 138.5 ± 8.6 vs 134.1 ± 8.3, p = 0.047;
MS20: 1.73 ± 0.59 vs 2.8 ± 1.12, p < 0.001). The number of PACs
n Holter monitoring was  signiﬁcantly higher in patients in the
F group than those in the non-AF group (149 ± 120 vs 79 ± 69;
 = 0.030). While age and plasma BNP concentrations tended to be
igher, LAD tended to be larger in the AF group than those in the
on-AF group, they did not reach statistical signiﬁcance. Cox pro-
ortional hazards analysis revealed that the presence of ALP (risk
atio 11.15; p = 0.002) and frequent PACs (more than 100/24 h) (risk
atio 4.53; p = 0.007) had signiﬁcant correlation to the occurrence
f AF (Table 2). Kaplan–Meier analysis showed that AF developed
igniﬁcantly more frequently in patients with than without ALP
p = 0.0019; Fig. 2). The ALP demonstrated a higher sensitivity and
peciﬁcity for the identiﬁcation of patients prone to AF compared
o frequent PACs (88.2% vs 64.7%, 62.7% vs 52.9%, respectively).AF, atrial ﬁbrillation; ALP, atrial late potentials; BNP, brain natriuretic peptide; CI,
conﬁdence interval; LAD, left atrial dimension; PAC, premature atrial contractions.
4. Discussion
Stroke patients who have AF are at high risk for recurrence,
which can be reduced by anticoagulation therapy [8].  The second
attack is often worse than the ﬁrst, leading to serious sequelae or
death. Therefore early diagnosis of AF is crucial, but may  be over-
looked when it is paroxysmal. Friberg et al. suggested that it is
important to increase the use of anticoagulants among patients
with paroxysmal AF because ischemic stroke is as common in
paroxysmal AF as in permanent AF [9].Fig. 1. Representative P-wave signal-averaged electrocardiography in each group.
It  is notable that the ﬁltered P-wave duration (FPD) is longer and the root-mean-
square voltage for the last 20 ms  (RMS20) is lower in the atrial ﬁbrillation (AF) patient
than in the non-AF patient.
K. Yodogawa et al. / Journal of Ca
Fig. 2. The Kaplan–Meier primary atrial ﬁbrillation (AF)-free curves for patients
with  and without atrial late potentials (ALP). The numbers at the bottom indicate
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[2] Okada Y, Shibazaki K, Kimura K, Iguchi Y, Miki T. Brain natriuretic peptide ashe number of patients in each group at risk for AF. The AF-free rate was  signiﬁcantly
ower in patients without than with ALP.
atients is still challenging. ALP detected by P-SAECG are thought
o originate from areas of delayed and heterogenous conduction
ithin the atrial myocardium, which are responsible for the occur-
ence of AF [4,5]. Previous studies have shown that P-SAECG is
seful for identifying patients who are at risk for AF development
fter CABG [10–13].  Yamada et al. demonstrated the utility of P-
AECG for prediction of AF in patients with congestive heart failure
7]. Moreover, Cic¸ ek et al. reported the predictive value of P-SAECG
fter acute myocardial infarction [14]. In the present study, we
pplied P-SAECG in stroke patients without clinical manifestation
f AF. The prevalence of ALP on P-SAECG was signiﬁcantly higher
n the AF group than those in the non-AF group, and the AF group
howed a signiﬁcantly longer FPD and lower RMS20 compared
o those in the non-AF group. Furthermore, multivariate analy-
is showed that the presence of ALP is independent and the most
owerful predictor of AF.
AF is often initiated by PACs that originate in the ostia of the
ulmonary veins [15]. Therefore frequent PACs on 24-h Holter
onitoring are thought to be associated with the development of
F, and actually this has been demonstrated in stroke patients who
re at risk for AF development [3].
In the present study, the number of PACs on Holter monitoring
as signiﬁcantly higher in patients in the AF group than those in
he non-AF group, and multivariate analysis showed that frequent
ACs is an independent predictor of AF development. These results
re consistent with the previous ﬁndings, indicating that frequent
ACs may  be useful for detection of patients who are prone to AF.
The incidence of atrial ﬁbrillation increases with age [16].
lthough our results showed that age tended to be higher in the
F group than those in the non-AF group, it did not reach statisti-
al signiﬁcance. Age-related structural changes in the atria such as
brosis may  be associated with development of AF.
Left atrial size is an important factor in the development of AF
17,18]. In the present study, LAD tended to be larger in the AF
roup than those in the non-AF group, but it did not reach statistical
igniﬁcance. Recent studies have shown that left atrial volume is a
uperior predictor to LA diameter for development of AF. Further
tudies including left atrial volume will be needed because it may
e a possible predictor for development of AF [18–20].BNP is a hormone released mainly from the cardiac ventricles
n response to myocardial wall stress, and associated with LV dys-
unction in various cardiac conditions. Plasma BNP concentrationrdiology 61 (2013) 49–52 51
is elevated in patients with paroxysmal AF, and maintenance of
sinus rhythm can reduce BNP levels [21,22]. Recently, Tamura et al.
showed that plasma BNP levels were markedly higher in patients
with cardioembolic stroke compared to those with cryptogenic
stroke [23]. The present study showed that plasma BNP concentra-
tions tended to be higher in the AF group than those in the non-AF
group, but it did not reach statistical signiﬁcance. Hemodynamic
change in acute phase of stroke may affect BNP levels. Tomita et al.
suggested that elevated plasma BNP levels are increased in acute
ischemic stroke independent of heart disease, and reﬂect the sever-
ity of stroke [24]. Furthermore, Nakagawa et al. reported that BNP
levels are increased in stroke patients even in patients without AF,
and they were correlated with mean arterial blood pressure on
admission [25].
It is noteworthy that about 40% of AF patients are asymptomatic.
This ﬁnding suggests that silent AF may  be present before stroke
attack. A recent trial has shown that patients who  experience
asymptomatic episodes of atrial tachycardia are prone to ischemic
stroke [26].
4.1. Study limitations
The current study has some limitations. First, the number of
patients is relatively small. Furthermore, our study population rep-
resented only 10% of the total ischemic stroke population (n = 711).
There is potential bias because many of patients were excluded for
aforementioned reasons. A prospective study in a larger number
of patients is necessary to deﬁne the clinical implication. Second,
there is not absolute proof that AF is a cause of stroke in our study.
Stroke in patients with AF is not necessarily due to cardiogenic
embolism, and other potential causes such as atheroesclerosis with
large artery disease may  exist. This is the most important limitation
of the present study. Third, the detection rate of new-onset AF using
routine Holter monitoring is limited, and silent AF episodes may  be
overlooked. In addition, the number of PACs on Holter monitoring
is affected by spontaneous variability. Therefore long-term Holter
monitoring may  have been needed for improvement of diagnostic
accuracy.
5. Conclusions
P-SAECG is useful to detect occult or silent AF. It should be con-
sidered in stroke of undetermined etiology.
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